Dr. Thomas Kallimopoulos

CEO at Extranthis UG

GermanyJoined April 2015


Elaboration of platform technologies for sustainable production of active pharmaceutical ingredients (API) from biomass and using sustainable ressources, respectful to the environment and clima change.
Development of natural products as drugs against addiction and pain management.

Work Experience (4)

R&D, Manufacturing Chemist, Marketing Manager

Givaudan SA

January 1991 - December 1996


General Manager

GK Amenities

December 1996 - January 2001


Marketing Manager


June 2001 - February 2009

Founding Partner

Extranthis UG (DE) & CORYN Pharmaceuticals LLC (USA)

February 2009 - Present


Academic Studies (5)

Chemical Engineer

University of Neuchâtel - Switzerland

January 1980 - January 1983



University of Neuchâtel - Switzerland

January 1983 - January 1987

Organic Chemistry

Post-doc studies

University of Neuchâtel - Switzerland

January 1987 - January 1988

Organic Synthesis

Research Associate

Columbia University NY - USA

January 1988 - January 1989


Research Associate

University of Neuchâtel - Switzerland

January 1989 - January 1991

Organic Synthesis

Research areas of interest (4)

  • Biological Sciences
  • Medicine, Human Health
  • Neurology, Brain Research
  • Pharmaceutical Products / Drugs

Dr. Thomas Kallimopoulos didn't publish any Technology Call yet

Our developed technology relates to the use of vegetable oil, a sustainable and green material, for the extraction and production in large scale of specific and highly useful alkaloid drugs as Active Pharmaceutical Ingredients (API), from biomass.[…]

Drug development of a natural product which presents a strong potential to treat addiction to opioids without developing addictive side effects to patients.[…]

- We provide supply of cGMP cytisine API in bulk, produced in FDA inspected installations in the USA, for use as smoking cessation agent. - We develop a small molecule (natural product) for treatment of opioids use disorder and for pain management.[…]

1. Synthèse des (1)-(6R)- et (+)-(6S)-tétrahydro-6-[(Z)-pent-2-ényl]-2H-pyran-2-one, lactones de Jasminum grandiflorum L.- et de Polianthes tuberosa L.. Helv. Chim. Acta. 74, 787¬790, (1991).

see publication

2. Synthèse énantiospécifique du (1)-(1S,3R,5R)-1,8-diméthyl-3-éthyl-2,9-dioxabicyclo [3.3.1]non-7-ène. Helv. Chim. Acta, 74, 1233-1235, (1991).

see publication

3. Structure-activity relationships of Philanthotoxin analogs and polyamines on N-Méthyl-D-Aspartate and Nicotinic Acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics, 254, 764-773, (1990).

see publication

4. Structure - activity relationships of analogues of the wasp toxin Philanthotoxin : Non-competitive antagonists of quisqualate receptors. Toxicon, 28, 1333-1346, (1990).

see publication

5. Philanthotoxine-433, (PhTx-433), a non-competitive glutamate receptor inhibitor. Pure Appl. Chem., 62, 1223- 1230, (1990).

see publication

6. Synthesis of glutamate receptor antagonist Philanthotoxine-433 (PhTx-433) and its analogs. Tetrahedron 46, 3267-3286, (1990).

see publication

7. Synthèse énantiospécifique du (1)-(1R,3R,5S)-diméthyl-1,3-dioxa-2,9-bicyclo-[3.3.1] nonane. Helv. Chim. Acta, 72, 1284-1287, (1989).

see publication

8. Synthèse énantiospécifique de la (+)-(R)-éthyl-6-dihydro-2,3-méthyl-2-4H-pyranone-4, phéromone de la mite Hepialus Hecta L.. Helv. Chim. Acta, 72, 1259-1261, (1989).

see publication

9. Synthèse énantiospécifique des acides (+)-(2R) et (-)-(2S)-éthyl-6-dihydro-3,4-méthyl-2-oxo-4-2H- pyranecarboxylique-5. Helv. Chim. Acta, 72, 731-737, (1989).

see publication

10. Structure of 1,5-Di(1-pyrrodinyl)-4-hexene-1,3-dione. Acta Cryst., C43, 2155-2157, (1987).

see publication

11. EP2292629 Method of isolating cytisine from biomaterial.

see patent at European Patent Office database

12. WO2011026637 Methods for isolating alkaloids from plants.

see patent at the European Patent Office database

Dr. Thomas Kallimopoulos didn't publish any Event yet

Dr. Thomas Kallimopoulos didn't publish any Job yet

Dr. Thomas Kallimopoulos didn't publish any New and Article yet

Dr. Thomas Kallimopoulos didn't publish any Education Resource yet

You are signed out

Join Innoget to connect with Dr. Thomas Kallimopoulos and thousands
of innovation-driven professionals and organizations